Cargando…
Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience
BACKGROUND: Certolizumab pegol (CZP) has been successfully used for the treatment of Crohn disease (CD); however, real-world data regarding the utility of CZP trough levels (CTLs) are lacking. We aimed to correlate CTL with CD outcomes and to determine frequency of CZP antibodies. METHODS: Retrospec...
Autores principales: | Ramos, Guilherme Piovezani, Al-Bawardy, Badr, Braga Neto, Manuel Bonfim, Bledsoe, Adam C, Quinn, Kevin P, Heron, Valérie, Willrich, Maria Alice V, Johnson, Amanda, Chedid, Victor G, Coelho-Prabhu, Nayantara, Kisiel, John B, Papadakis, Konstantinos A, Pardi, Darrell, Kane, Sunanda, Tremaine, William J, Raffals, Laura, Bruining, David H, Faubion, William A, Harmsen, William S, Loftus, Edward V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802288/ https://www.ncbi.nlm.nih.gov/pubmed/36776673 http://dx.doi.org/10.1093/crocol/otab019 |
Ejemplares similares
-
The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis
por: Aniwan, Satimai, et al.
Publicado: (2019) -
Approach to medical therapy in perianal Crohn’s disease
por: Vasudevan, Abhinav, et al.
Publicado: (2021) -
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis
por: Fredrick, Thomas W, et al.
Publicado: (2022) -
Case report: Pentoxifylline treatment in microscopic colitis
por: Cotter, Thomas G., et al.
Publicado: (2017) -
Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010
por: Aniwan, Satimai, et al.
Publicado: (2019)